Current prognostic factors in breast cancer include tumor characteristics such as tumor size, the status of axillary lymph nodes and grade, as well as immunohistochemistry-based tumor markers such as the estrogen receptor (ER), progesterone receptor (PgR), the proliferation marker Ki67 and ERBB2 expression [2, 4–9]. This evidence concerns the gene MKI67 and neoplasm.